UB Paderborn / Katalog / Suche / in CDI

KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5931-5937

2009

Link zum Volltext

Verfügbarkeit prüfen

Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5439-5444

2009

Link zum Volltext

Verfügbarkeit prüfen

Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial

Journal of clinical oncology, 2008-06, Vol.26 (16), p.2690-2698

2008

Link zum Volltext

Verfügbarkeit prüfen

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (18), p.7017-7026

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

The lancet oncology, 2012-12, Vol.13 (12), p.1242-1249

2012

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

Clinical cancer research, 2009-11, Vol.15 (22), p.6939-6946

2009

Link zum Volltext

Verfügbarkeit prüfen

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy

Oncotarget, 2014-05, Vol.5 (10), p.3273-3286

2014

Link zum Volltext

Verfügbarkeit prüfen

Combined epiregulin (EREG) and amphiregulin (AREG) expression levels as a biomarker of prognosis and panitumumab benefit in RAS -wt advanced colorectal cancer (aCRC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3520-3520

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Adenomas and Hyperplastic Polyps in Mismatch Repair Mutation Carriers Among CAPP2 Participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3434-3439

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis of variants in DNA damage signalling genes in bladder cancer

BMC medical genetics, 2008-07, Vol.9 (1), p.69-69, Article 69

2008

Link zum Volltext

Verfügbarkeit prüfen

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

The Lancet (British edition), 2020-06, Vol.395 (10240), p.1855-1863

2020

Link zum Volltext

Verfügbarkeit prüfen

CAPP2 RCT: Resistant Starch Planned Long-term Follow-up-Reply

Cancer prevention research (Philadelphia, Pa.), 2023-01, Vol.16 (1), p.59-59

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

The Lancet (British edition), 2011-12, Vol.378 (9809), p.2081-2087

2011

Link zum Volltext

Verfügbarkeit prüfen

Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK

Journal of clinical pathology, 2019-07, Vol.72 (7), p.482

2019

Link zum Volltext

Verfügbarkeit prüfen

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

BMC medical genetics, 2011-06, Vol.12 (1), p.84-84, Article 84

2011

Link zum Volltext

Verfügbarkeit prüfen

Surgical excision methods for skin cancer involving the nail unit

Cochrane database of systematic reviews, 2021-05, Vol.2021 (5)

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.203-203

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone

British journal of cancer, 2021-10, Vol.125 (8), p.1080-1088

2021

Link zum Volltext

Verfügbarkeit prüfen

The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3540-3540

2022

Link zum Volltext

Verfügbarkeit prüfen

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

Carcinogenesis (New York), 2012-03, Vol.33 (3), p.581-586

2012

Link zum Volltext

Verfügbarkeit prüfen

A population-based analysis of germline BAP1 mutations in melanoma

Human molecular genetics, 2017-02, Vol.26 (4), p.717-728

2017

Link zum Volltext

Verfügbarkeit prüfen

Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

Clinical cancer research, 2021-06, Vol.27 (12), p.3422-3431

2021

Link zum Volltext

Verfügbarkeit prüfen

Surgical excision methods for skin cancer involving the nail unit: A systematic review

Cochrane evidence synthesis and methods, 2023-10, Vol.1 (8)

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma

Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations

Combined epiregulin (EREG) and amphiregulin (AREG) expression levels as a biomarker of prognosis and panitumumab benefit in RAS -wt advanced colorectal cancer (aCRC)

Prevalence of Adenomas and Hyperplastic Polyps in Mismatch Repair Mutation Carriers Among CAPP2 Participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2

Analysis of variants in DNA damage signalling genes in bladder cancer

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

CAPP2 RCT: Resistant Starch Planned Long-term Follow-up-Reply

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

Surgical excision methods for skin cancer involving the nail unit

Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study

Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone

The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC)

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

A population-based analysis of germline BAP1 mutations in melanoma

Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

Surgical excision methods for skin cancer involving the nail unit: A systematic review

Suchergebnisse filtern